483 Blair M. Brengle, M.D. Jul 2021

483 Blair M. Brengle, M.D. Jul 2021

Myra Casey FDA, Dina Tallman FDA$119.00 - Available Now

FDA investigators audited the Blair M. Brengle, M.D. - Indianapolis, IN, United States facility and issued inspectional observations (via FDA 483) on 08 Jul 2021.

Product details

  • Category: Human Drugs
  • Inspection end: 08 Jul 2021
  • Location: Indianapolis, United States
  • FEI: 3018034336
Add To Cart